To our knowledge, this is the first clinical research to assess the anti-inflammatory effect of high-dose atorvastatin in major depressive disorders through AMPK/NLRP3 and IL-6/STAT-3 signaling pathways. The gene discussed is IL6; the disease is major depressive disorder.